Dec 06, 2016 21:07 pm UTC| Business
DALLAS, Dec. 06, 2016 -- Dave Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave Buster's" or "the "Company"), an owner and operator of entertainment and dining venues, today announced the promotion of Margo Manning...
PDC Energy Closes Core Delaware Basin Acquisition
Dec 06, 2016 21:05 pm UTC| Business
DENVER, Dec. 06, 2016 -- PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today announced that the Company closed the previously announced Delaware Basin acquisition. Acquisition Highlights Closing price of...
Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference
Dec 06, 2016 21:05 pm UTC| Business
GAITHERSBURG, Md., Dec. 06, 2016 -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in the 4th Annual Guggenheim Boston Healthcare Conference. Conference details are as follows: Date:...
HealthEquity Reports Third Quarter Ended October 31, 2016 Financial Results
Dec 06, 2016 21:05 pm UTC| Business
Highlights of the third quarter include: Revenue of $43.4 million, an increase of 42% compared to Q3 FY16.Net income of $6.0 million, an increase of 47% compared to Q3 FY16.Net income per diluted share of $0.10, compared...
Dave & Buster’s Entertainment, Inc. Announces Third Quarter 2016 Financial Results
Dec 06, 2016 21:05 pm UTC| Business
Achieves Net Income of $10.8 Million and Diluted EPS of $0.25Delivers 5.9% Increase in Comparable Store Sales and 42% Adjusted EBITDA GrowthRaises Full Year 2016 Guidance DALLAS, Dec. 06, 2016 -- Dave Buster's...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Dec 06, 2016 21:05 pm UTC| Business
TUSTIN, Calif., Dec. 06, 2016 -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E...
Dec 06, 2016 21:05 pm UTC| Business
Lower proteinuria in blisibimod versus placebo treated patientsChanges in circulating B-cells and serum immunoglobulins consistent with BAFF inhibition HAYWARD, Calif., Dec. 06, 2016 -- Anthera Pharmaceuticals, Inc....